Kenji Ishitsuka

18PUBLICATIONS
92CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursEpidemiology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 15, 2025
A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia/lymphoma.

Makoto Yoshimitsu, Ilseung Choi, Shigeru Kusumoto

|Jun 07, 2024
Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4-positive peripheral T-cell lymphoma and relapsed or refractory cutaneous T-cell lymphoma: A post-marketing surveillance in Japan.

Kenji Ishitsuka, Tomoharu Yasukawa, Yukie Tsuji

|Nov 03, 2023
Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphoma.

Koji Izutsu, Takahiro Kumode, Junichiro Yuda

|Mar 15, 2023
T cell lymphoma: time to make discoveries and advance treatment.

Kenji Ishitsuka

|Feb 22, 2023
Identification of putative noncanonical driver mutations in patients with essential thrombocythemia.

Akihiko Arai, Makoto Yoshimitsu, Maki Otsuka

|Feb 16, 2023
Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.

Naoko Hosono, SungGi Chi, Takahiro Yamauchi

Pageof 3

Frequent Collaborators

10 joint publications

Makoto Yoshimitsu

5 joint publications

Masahito Tokunaga

5 joint publications

Atae Utsunomiya

5 joint publications

Kisato Nosaka